TTP889

DRUG2 trials

Sponsors

vTv Therapeutics

Conditions

CoagulationEmbolism and ThrombosisHip FracturesVenous Thromboembolism

Phase 2

Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)

CompletedNCT00119457

vTv TherapeuticsEmbolism and Thrombosis, Hip Fractures, Venous Thromboembolism

Start: 2005-01-31End: 2006-04-30Target: 300Updated: 2009-06-03

Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA)

TerminatedNCT00909298

vTv TherapeuticsCoagulation

Start: 2009-06-30Updated: 2011-06-27

Related Papers

Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study.

2007-12-1237 citations